Shanghai HeartCare Medical Technology Sets January 16, 2026 Date for Extraordinary and Class Shareholder Meetings

Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has provided an update.

Shanghai HeartCare Medical Technology Corporation Limited has reminded shareholders of its upcoming extraordinary general meeting and separate class meetings for H shareholders and unlisted shareholders, all scheduled to start at 10:00 a.m. on Friday, January 16, 2026, at SealMed Hall in Shanghai. Holders of H shares whose names appear on the company’s H share register on that date will be entitled to attend and vote on the proposed resolutions, signalling a key governance event that may influence capital structure or shareholder rights and underscores the company’s efforts to ensure active participation and compliance with Hong Kong listing requirements.

The most recent analyst rating on (HK:6609) stock is a Buy with a HK$67.00 price target. To see the full list of analyst forecasts on Shanghai Heartcare Medical Technology Corp. Ltd. Class H stock, see the HK:6609 Stock Forecast page.

More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H

Shanghai HeartCare Medical Technology Corporation Limited is a PRC-incorporated medical technology company listed in Hong Kong (stock code: 6609), focused on developing and commercialising cardiovascular-related medical devices and technologies for both domestic and international markets.

Average Trading Volume: 66,531

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.41B

See more insights into 6609 stock on TipRanks’ Stock Analysis page.